Enclomiphene is a selective estrogen receptor modulator (SERM) widely discussed in post-cycle and hormone-recovery research. Below, we compare vendors currently stocking research-grade Enclomiphene — not just a single sales page.
Prices and testing claims are pulled from each vendor's product listing. Always confirm current price and COA (Certificate of Analysis) on the vendor's site before buying.
| Vendor | Price | Purity Testing | Code | |
|---|---|---|---|---|
 MuscleChemBest Value |
£59.99 | In-house testing | Buy Here → | |
 Next Chem |
$79.95 | Third-party COA | Auto-applied | Buy Here → |
 Chemyo |
$79.99 (12.5mg/ml solution) | Third-party COA | Buy Here → |
Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) long used in fertility medicine. Isolating enclomiphene from the mixed-isomer clomiphene formulation has been studied specifically for its effects on testosterone without the estrogenic isomer (zuclomiphene) associated with clomiphene's side effects.
Research-grade Enclomiphene is typically supplied as capsules or a liquid solution, commonly at 12.5mg to 25mg per dose, intended for laboratory research use.
Enclomiphene blocks estrogen receptors in the hypothalamus, disrupting the negative-feedback signal that estrogen normally sends to suppress LH and FSH release — the pathway studied for restoring endogenous testosterone production, distinct from exogenous testosterone replacement.
Enclomiphene has been researched for its ability to raise LH, FSH, and endogenous testosterone levels while preserving fertility and testicular function, which is why it is frequently discussed in post-cycle-therapy research contexts as an alternative to full SERMs like clomiphene.
Clinical trials have specifically studied enclomiphene as a potential treatment for secondary hypogonadism in men who wish to preserve fertility, an area where it has more targeted human trial data than many PCT-related compounds.
Clomiphene (containing enclomiphene) has an established human safety record from decades of fertility use, including known effects such as visual disturbances, mood changes, and hot flashes; standalone enclomiphene has been studied in more limited Phase 2 trials and has not received independent FDA approval as its own product.
Doses studied in enclomiphene clinical trials and doses used in fertility-context clomiphene prescribing are documented in that respective literature; no FDA-approved standalone enclomiphene dosage exists for research use.
Compound X does not sell Enclomiphene directly. We provide independent research, comparisons and vendor links — see the vendor comparison table above for current US, UK, Canada and Australia options.
Enclomiphene clinical trial data is indexed on PubMed under "Enclomiphene citrate hypogonadism trial" and "trans-clomiphene testosterone."
New guides, vendor comparisons and compound breakdowns every week.